Saturday, September 19, 2020

India’s first CRISPR Covid-19 test, developed by the Tata Group and CSIR-IGIB, approved for use in India

This test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of SARS-CoV-2 virus. CRISPR is a genome editing technology to diagnosing diseases.


No comments:

Post a Comment